Transfusion-related acute lung injury: current concepts for the clinician

Anesthesia and Analgesia

Volumn 108, Issue 3, 2009, Pages 770-776

  Triulzi, Darrell J ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; FRESH FROZEN PLASMA; HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; LEUKOCYTE ANTIBODY; NEUTROPHIL SPECIFIC ANTIGEN; OXIDOREDUCTASE; UNCLASSIFIED DRUG; ANTIBODY;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTIFICIAL VENTILATION; BLOOD COMPONENT; BLOOD DONOR; BLOOD TRANSFUSION REACTION; CAPILLARY LEAK SYNDROME; CELL ACTIVATION; CELLULAR DISTRIBUTION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DONOR SELECTION; HEART FAILURE; HUMAN; HYPOXIA; INCIDENCE; INTENSIVE CARE UNIT; LABORATORY DIAGNOSIS; LUNG EDEMA; LUNG ENDOTHELIUM; MORBIDITY; MORTALITY; NEUTROPHIL; OXYGEN THERAPY; PATHOGENESIS; PATHOPHYSIOLOGY; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; THROMBOCYTOPHERESIS; TRANSFUSION ASSOCIATED CIRCULATORY OVERLOAD; TRANSFUSION RELATED ACUTE LUNG INJURY; ACUTE DISEASE; BLOOD TRANSFUSION; IMMUNOLOGY; LUNG DISEASE; PEROPERATIVE COMPLICATION;

ACUTE DISEASE; ANTIBODIES; BLOOD TRANSFUSION; HUMANS; INTRAOPERATIVE COMPLICATIONS; LUNG DISEASES; RISK FACTORS;

EID: 61949237566     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e31819029b2     Document Type: Article

References (54)

1. Goldman M, Webert KE, Arnold DM, Freedman J, Hannon J, Blajchman MA. Proceedings of a consensus conference: towards and understanding of TRALI. Transfus Med Rev 2005;19:2-31
2. Brittingham TE. Immunologic studies on leukocytes. Vox Sang 1957;2:242-8
3. Popovsky MA, Abel MD, Moore SB. Transfusion related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis 1983;128:185-9
4. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985;25:573-7
5. Toy P, Popovsky MA, Abraham E, Ambruso DR, Holness LG, Kopko PM, McFarland JG, Nathens AB, Silliman CS, Stroncek D. The National Heart Lung and Blood Institute Working Group on TRALI. Transfusion-related acute lung injury: definition and review. Crit Care Med 2005;33:721-6
6. Kleinman S, Caufield T, Chan P, Davenport R, McFarland J, McPhedran S, Meade M, Morrison D, Pinsent T, Robillard P, Slinger P. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004;44:1774-89
7. Zhou L, Giacherio D, Cooling L, Davenport RD. Use of B-natriuretic peptide as a diagnostic marker in the differential diagnosis of transfusion-associated circulatory overload. Transfusion 2005;45:1056-63
8. Nakagawa M, Toy P. Acute and transient decrease in neutrophil count in transfusion-related acute lung injury: cases at one hospital. Transfusion 2004;44:1689-94
9. Gajic O, Gropper MA, Hubmayr RD. Pulmonary edema after transfusion: how to differentiate transfusion associated circulatory overload from transfusion related acute lung injury. Crit Care Med 2006;34(suppl):S109-13
10. Webert KE, Blajchman MA. Transfusion-related acute lung injury. Curr Opin Hematol 2005;12:480-7
11. Wallis JP. Transfusion-related acute lung injury (TRALI): presentation, epidemiology and treatment. Intensive Care Med 2007;33(suppl 1):S12-16
12. Holness L, Knippen MA, Simmons L, Lachenbruch PA. Fatalities caused by TRALI. Transfus Med Rev 2004;18:184-8
13. Fatalities reported to the FDA following blood collection and transfusion. In: Proceedings of the Annual Summary for Fiscal Years 2005 and 2006. Available at http://www.fda.gov/CBER/blood/fatal0506.htm. Accessed March 3, 2008
14. Rizk A, Gorson KC, Kenney L, Weinstein R. Transfusion-related acute lung injury after the infusion of IVIG. Transfusion 2001;41:264-8
15. Eder AF, Herron R, Strupp A, Edward BD, Notari EP, Chambers LA, Dodd RY, Benjamin RJ. Transfusion related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 2007;47:599-607
16. Serious Hazards of Transfusion, 2004 Annual Report. Available at: http:www.shot-uk.org
17. Gajic O, Rana R, Winters J, Yilmaz M, Mendez JL, Rickman OB, O'Byrne MM, Evenson LK, Malinchoc M, DeGoey SR, Afessa B, Hubmayr RD, Moore SB. Transfusion-related acute lung injury in the critically ill: prospective nested case control study. Am J Respir Crit Care Med 2007;176:886-91
18. Bux J, Sachs UJ. The pathogenesis of transfusion related acute lung injury (TRALI). Br J Haematol 2007;136:788-99
19. Sachs UJ. Pathophysiology of TRALI: current concepts. Intensive Care Med 2007;33(suppl 1):S3-11
20. Popovsky MA, Haley NR. Further characterization of transfusion-related acute lung injury: demographics: clinical and laboratory features, and morbidity. Immunohematology 2000;16:157-9
21. Kopko PM, Paglieroni TG, Popovsky MA, Muto KN, MacKenzie MR, Holland PV. TRALI: correlation of antigen-antibody and monocyte activation in donor recipient pairs. Transfusion 2003;43:177-84
22. Wallis JP, Lubenko A, Wells AW, Chapman CE. Single hospital experience of TRALI. Transfusion 2003;43:1053-9
23. Kopko PM, Popovsky MA, MacKenzie MR, Paglieroni TG, Muto KN, Holland PV. HLA class II antibodies in transfusionrelated acute lung injury. Transfusion 2001;41:1244-8
24. Kao GS, Wood IG, Dorfman DM, Milford EL, Benjamin RJ. Investigations into the role of anti-HLA class II antibodies in TRALI. Transfusion 2003;43:185-91
25. Davoren A, Curtis BR, Shulman IA, Mohrbacher AF, Bux J, Kwiatkowska BJ, MacFarland JG, Aster RH. TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities. Transfusion 2003;43:641-5
26. Englelfriet CP, Reesink HW, Brand A, Palfi M, Popovsky MA, Martin-Vega C, Ribera A, Rouger P, Goldman M, Decary F, Freedman J, Lucas G, Navarette C, Neppert J, Lin M, Zupanska B. Transfusion-related acute lung injury (TRALI). Vox Sang 2001;81:269-83
27. Bux J, Becker F, Seeger W, Kilpatrick D, Chapman J, Waters A. Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB-1 specific antibodies in donor blood. Br J Haematol 1996;93:707-13
28. Sachs UJ, Bux J. TRALI after the transfusion of cross-matchpositive granulocytes. Transfusion 2003;43:1683- 6
29. Triulzi D, Kakaiya R, Kleiman S, Busch M, Norris P, Steele W, Hillyer CD, Schreiber G. Relationship of HLA antibodies in blood donors to pregnancy and transfusion history. Transfusion 2007;47(suppl 2):2A
30. MacLennan S, Lucas G, Brown C, Evans R, Kallon D, Brough S, Contreras M, Navarrete C. Prevalence of HLA and HNA antibodies in donors: correlation with pregnancy and transfusion history. Vox Sang 2004;87(suppl 3):S2-16
31. Clay M, Kline W, McCullough J. The frequency of granulocyte specific antibodies in postpartum sera and a family study of the 6B antigen. Transfusion 1984;24:252-5
32. Seeger W, Schneider U, Kreusler B, Witzleben EV, Walmrath D, Grimminger F, Neppert J. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood 1990; 76:1438-44
33. Looney MR, Su X, Van Ziffle JA, Lowell CA, Matthay MA. Neutrophils and their Fc- receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest 2006;116:1615-23
34. Sachs UJ, Hattar K, Weissmann N, Bohle RM, Siblelius U, Bux J. Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury. Blood 2006;107:1217-19
35. Silliman CC, Curtis BR, Kopko PM, Khan SY, Kelher MR, Schuller RM, Sannoh B, Ambruso DR. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood 2007;109:1752-5
36. Dooren MC, Ouwehand WH, Verhoeven AJ, von dem Borne AE, Kuijpers RW. Adult respiratory distress syndrome after experimental intravenous gamma-globulin concentrates and monocyte-reactive IgG antibodies. Lancet 1998;352:1601-2
37. Palfi M, Berg S, Ernerudh J, Berlin G. A randomized controlled trial of transfusion-related acute lung injury: is plasma from multiparous blood donors dangerous? Transfusion 2001;41: 317-22
38. Dykes A, Smallwood D, Kotsimbos T, Treet A. Transfusion related acute lung injury (TRALI) in a patient with a single lung transplant. Br J Haematol 2000;109:674-6
39. Wright SE, Snowden CP, Athey SC, Leaver AA, Clarkson JM, Chapman CE, Roberts DRD, Wallis JP. Acute lung injury after abdominal aortic aneurysm repair: the effect of excluding donations from females from the production of fresh frozen plasma. Crit Care Med 2008;36:1796-802
40. Toy P, Hollis-Perry KM, Jun J, Nakagawa M. Recipients of blood from a donor with multiple HLA antibodies: a lookback study of transfusion-related acute lung injury. Transfusion 2004;44: 1683-8
41. Kopko PM, Marshall CS, Mackenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA 2002;287:1968-71
42. Silliman CC, Ambruso DR, Boshkov LK. Transfusion-related acute lung injury. Blood 2005;105:2266-73
43. Silliman CC, Kelher M. The role of endothelial activation in the pathogenesis of transfusion-related acute lung injury. Transfusion 2005;45(suppl):S109-16
44. Silliman CC, Voelkel NF, Allard JD, Elzi DJ, Tuder RM, Johnson JL, Ambruso DR. Plasma and lipids from stored red cells cause acute lung injury in an animal model. J Clin Invest 1998; 101:1458-67
45. Silliman CC, Bjornsen AJ, Wyman TH, Kelher M, Allard J, Bieber S, Voelkel NF. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion 2003; 43:633-40
46. Khan SY, Kelher MR, Heal JM, Blumberg N, Boshkov LK, Phipps R, Gettings KF, McLaughlin NJ, Silliman CC. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a cofactor in the development of transfusion-related acute lung injury. Blood 2006;108:2455-62
47. Silliman CC, Boshkov LK, Mehdizadehkashi Z, Elzi DJ, Dickey WO, Podlosky L, Ckarke G, Ambruso DR. Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors. Blood 2003;101:454-62
48. Silliman CC, Paterson AJ, Dickey WO, Stroncek DF, Popovsky MA, Caldwell SA, Ambruso DR. The association of biologically active lipids with the development of transfusion-related acute lung injury: a retrospective study. Transfusion 1997;37:719-26
49. AABB Standards for blood banks and transfusion services. 24th ed. Bethesda, MD: AABB Press, 2006
50. Su L, Kamel H. How do we investigate and manage donors associated with a suspected case of transfusion-related acute lung injury. Transfusion 2007;47:1118-24
51. Chapman CE, Williamson LM, Cohen H, Stainsby D, Jones H. The impact of using male donor plasma on haemovigilance reports of transfusion associated acute lung injury (TRALI) in the UK (abstract). Vox Sang 2006;91(suppl 3):227
52. Sachs UJH, Kauschat D, Bein G. White blood cell-reactive antibodies are undetectable in solvent/detergent plasma. Transfusion 2005;45:1628-31
53. AABB Association Bulletin 06-07. Transfusion-related acute lung injury, 2006. Available at http://www.aabb.org
54. Triulzi D, Kakaiya R, Schreiber G. Donor risk factors for white blood cell antibodies associated with transfusion related acute lung injury: REDS II Leukocyte Antibody Prevalence Study (LAPS). Transfusion 2007;47:563-4